National protocols
- 01/04/2022
- National protocol for live attenuated influenza vaccine nasal spray suspension (LAIV)
-
-
-
Authorisation protocol for live attenuated influenza vaccine nasal spray suspension to individuals in accordance with the national influenza vaccination programme.
- 01/04/2022
- National protocol for inactivated influenza vaccine (IIV)
-
-
-
Authorisation protocol for the administration of inactivated influenza vaccine to individuals in accordance with the national influenza vaccination programme.
- 01/04/2022
- National Protocol for COVID-19 Janssen vaccine
-
-
-
Authorisation protocol for non-registered professionals to immunise people with the Janssen vaccine.
- 01/04/2022
- National Protocol for COVID-19 Moderna (Spikevax) vaccine
-
-
-
Authorisation protocol for non-registered professionals to immunise people with the National Protocol for COVID-19 Moderna (Spikevax) vaccine.
- 01/04/2022
- National protocol for COVID-19 AstraZeneca (Vaxzevria) vaccine
-
-
-
Authorisation protocol for non-registered professionals to immunise people with the AstraZeneca (Vaxzevria) COVID-19 vaccine.
- 01/04/2022
- National protocol for Comirnaty (Children 5-11 years) COVID-19 mRNA vaccine
-
-
-
Authorisation protocol for non-registered professionals to immunise people with the Comirnaty (Children 5-11 years) COVID-19 mRNA vaccine.
- 01/04/2022
- National Protocol for Comirnaty 30micrograms/dose COVID-19 mRNA vaccine
-
-
-
Authorisation protocol for non-registered professionals to immunise people with the Comirnaty COVID-19 mRNA vaccine.